Meet time-sensitive enrollment goal of 496 patients in order to extend labeling for client’s FDA-approved neurostimulation device for the treatment of peripheral neuropathy in post-stroke patients.
ThreeWire developed an comprehensive solution to maximize enrollment that included a detailed media outreach campaign tailored to each site’s unique needs. ThreeWire also created a study-specific website with self-screener. Respondents were prescreened in our Patient Interaction Center® (PIC) before being referred to sites. ThreeWire’s Site Services group ensured that each site received the proper number of referrals and processed each patient through to enrollment.
ThreeWire contributed 204 patients, or 42% of the total enrollment goal. Our high-quality prescreening process and site services were key factors in allowing us to close enrollment ahead of schedule and under budget.
“Thanks for all you and the team are doing in support of this study!”
- Study Project Manager Top 10 Pharma Company